Abstract
The great potential of nucleic acids as therapeutics has been recognized for a while but has experienced a tremendous attention with the recent development of RNA vaccines. In contrast to protein-targeting strategies, nucleic acid-based approaches often have the advantage that the required target selectivity is not realized via matching a specific structure, but plainly via the primary sequence of the applied RNA or DNA construct. This sequence is then either directly processed or comprises an additional unit capable of processing a target molecule. The latter is true for a number of DNA sequences, called DNAzymes, that are capable of both binding and processing a target with a high selectivity. While the mRNA technology has the inherent strength of bringing something into the system, RNA-processing DNA catalysts such as RNA-cleaving DNAzymes have the inherent strength of taking something out of the system. Consequently, the DNAzyme technology has the potential to emerge as counterpart to the mRNA technology. However, and in line with the endeavors that were required for the success of the mRNA technology, specific improvements need to be realized to unravel the full potential of RNA-processing DNAzymes. This review provides an overview of recent findings and remaining limitations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Appaiahgari MB, Vrati S (2007) DNAzyme-mediated Inhibition of Japanese encephalitis virus replication in mouse brain. Mol Ther 15:1593–1599
Baum DA, Silverman SK (2008) Deoxyribozymes: useful DNA catalysts in vitro and in vivo. Cell Mol Life Sci 65:2156–2174
Borggräfe J, Gertzen CGW, Viegas A et al (2022a) The architecture of the 10–23 DNAzyme and its implications for DNA-mediated catalysis. FEBS J in Press: https://doi.org/10.1111/febs.16698
Borggräfe J, Victor J, Rosenbach H et al (2022b) Time-resolved structural analysis of an RNA-cleaving DNA catalyst. Nature 601:144–149
Breaker RR (1997) DNA enzymes. Nat Biotechnol 15:427–431
Breaker RR, Joyce GF (1994) A DNA enzyme that cleaves RNA. Chem Biol 1:223–229
Cai H, Santiago FS, Prado-Lourenco L et al. (2012) DNAzyme targeting c-jun suppresses skin cancer growth. Sci Transl Med 4:139ra82
Cairns MJ, Sun L-Q (2004) Target-site selection for the 10–23 DNAzyme. Methods Mol Biol 252:267–277
Cao Y, Yang L, Jiang W et al (2014) Therapeutic evaluation of Epstein-barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas. Mol Ther 22:371–377
Chandra M, Sachdeva A, Silverman SK (2009) DNA-catalyzed sequence-specific hydrolysis of DNA. Nat Chem Biol 5:718–720
Chandrasekar J, Silverman SK (2013) Catalytic DNA with phosphatase activity. Proc Natl Acad Sci USA 110:5315–5320
Chandrasekar J, Wylder AC, Silverman SK (2015) Phosphoserine lyase deoxyribozymes: DNA-catalyzed formation of dehydroalanine residues in peptides. J Am Chem Soc 137:9575–9578
Chinnapen DJF, Sen D (2004) A deoxyribozyme that harnesses light to repair thymine dimers in DNA. Proc Natl Acad Sci USA 101:65–69
Cho EA, Moloney FJ, Cai H et al (2013) Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: A phase 1 first-in-human trial (DISCOVER). Lancet 381:1835–1843
Chu C-C, Wong OY, Silverman SK (2014) A generalizable DNA-catalyzed approach to peptide-nucleic acid conjugation. ChemBioChem 15:1905–1910
Cuchillo CM, Nogués MV, Raines RT (2011) Bovine pancreatic ribonuclease: Fifty years of the first enzymatic reaction mechanism. Biochemistry 50:7835–7841
Cuenoud B, Szostak JW (1995) A DNA metalloenzyme with DNA ligase activity. Nature 375:611–614
Culbertson MC, Temburnikar KW, Sau SP et al (2016) Evaluating TNA stability under simulated physiological conditions. Bioorg Med Chem Lett 26:2418–2421
Dicke T, Pali-Schöll I, Kaufmann A et al (2012) Absence of unspecific innate immune cell activation by GATA-3-specific DNAzymes. Nucleic Acid Ther 22:117–126
Dunham CM, Murray JB, Scott WG (2003) A helical twist-induced conformational switch activates cleavage in the hammerhead ribozyme. J Mol Biol 332:327–336
Flynn-Charlebois A, Wang Y, Prior TK et al (2003) Deoxyribozymes with 2′-5′ RNA ligase activity. J Am Chem Soc 125:2444–2454
Fratini AV, Kopka ML, Drew HR et al (1982) Reversible bending and helix geometry in a B-DNA dodecamer: CGCGAATTBrCGCG. J Biol Chem 257:14686–14707
Freund N, Taylor AI, Arangundy-Franklin S et al (2022) A two-residue nascent-strand steric gate controls synthesis of 2′-O-methyl- and 2′-O-(2-methoxyethyl)-RNA. Nat Chem in Press. https://doi.org/10.1038/s41557-022-01050-8
Gerber PP, Donde MJ, Matheson NJ et al (2022) XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection. Nat Commun 13:6716
Gu H, Furukawa K, Weinberg Z et al (2013) Small, highly active DNAs that hydrolyze DNA. J Am Chem Soc 135:9121–9129
Hadjiolov AA, Venkov PV, Tsanev RG (1966) Ribonucleic acids fractionation by density-gradient centrifugation and by agar gel electrophoresis: A comparison. Anal Biochem 17:263–267
Hamilton AJ, Baulcombe DC (1999) A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 286:950–952
Hervey JRD, Freund N, Houlihan G et al (2022) Efficient synthesis and replication of diverse sequence libraries composed of biostable nucleic acid analogues. RSC Chem Biol 3:1209–1215
Hoagland MB, Stephenson ML, Scott JF et al (1958) A soluble ribonucleic acid intermediate in protein synthesis. J Biol Chem 231:241–257
Hollenstein M (2015) DNA catalysis: The chemical repertoire of DNAzymes. Molecules 20:20777–20804
Homburg U, Turowska A, Kuhlmann J et al (2013) Safety profile and pharmacokinetics of SB010, an inhaled GATA-3-specific DNAzyme, in phase I clinical trials in healthy and asthmatic subjects. Eur Respir J 42:4858
Huang P-JJ, Liu J (2015) Rational evolution of Cd2+-specific DNAzymes with phosphorothioate modified cleavage junction and Cd2+ sensing. Nucleic Acids Res 43:6125–6133
Jakobsen MR, Haasnoot J, Wengel J et al (2007) Efficient inhibition of HIV-1 expression by LNA modified antisense oligonucleotides and DNAzymes targeted to functionally selected binding sites. Retrovirology 4:29
Kruger K, Grabowski PJ, Zaug AJ et al (1982) Self-splicing RNA: Autoexcision and autocyclization of the ribosomal RNA intervening sequence of tetrahymena. Cell 31:147–157
Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843–854
Littlefield JW, Keller EB, Gross J et al (1955) Studies of cytoplamsic ribonucleoprotein particles from the liver of the rat. J Biol Chem 217:111–124
Liu H, Yu X, Chen Y et al (2017) Crystal structure of an RNA-cleaving DNAzyme. Nat Commun 8:2006
Ma L, Liu J (2020) Catalytic nucleic acids: biochemistry, chemical biology, biosensors, and nanotechnology. iScience 23:100815
McQuillen K, Roberts RB, Britten RJ (1959) Synthesis of nascent protein by ribosomes in Escherichia Coli. Proc Natl Acad Sci USA 45:1437–1447
Micura R, Höbartner C (2020) Fundamental studies of functional nucleic acids: Aptamers, riboswitches, ribozymes and DNAzymes. Chem Soc Rev 49:7331–7353
Mohammadi-Arani R, Javadi-Zarnaghi F, Boccaletto P et al (2022) DNAzymeBuilder, a web application for in situ generation of RNA/DNA-cleaving deoxyribozymes. Nucleic Acids Res 50:W261–W265
Morrison D, Rothenbroker M, Li Y (2018) DNAzymes: Selected for applications. Small Methods 2:1700319
Nguyen K, Wang Y, England WE et al (2021) Allele-specific RNA knockdown with a biologically stable and catalytically efficient XNAzyme. J Am Chem Soc 143:4519–4523
Nowakowski J, Shim PJ, Prasad GS, a. (1999) Crystal structure of an 82-nucleotide RNA-DNA complex formed by the 10–23 DNA enzyme. Nat Struct Biol 6:151–156
Pechlaner M, Sigel RKO (2012) Characterization of metal ion-nucleic acid interactions in solution. Metal Ions in Life Sciences, pp 1–42
Ponce-Salvatierra A, Wawrzyniak-Turek K, Steuerwald U et al (2016) Crystal structure of a DNA catalyst. Nature 529:231–234
Pradeepkumar PI, Höbartner C, Baum DA et al (2008) DNA-catalyzed formation of nucleopeptide linkages. Angew Chemie - Int Ed 47:1753–1757
Pradeepkumar PI, Höbartner C (2012) RNA-cleaving DNA enzymes and their potential therapeutic applications as antibacterial and antiviral agents. From Nucleic Acids Sequences to Molecular Medicine Berlin, Heidelberg: Springer Berlin Heidelberg. pp 371–410
Pyle AM, Chu VT, Jankowsky E et al (2000) Using DNAzylnes to cut, process, and map RNA molecules for structural studies or modification. Methods Enzymol 317:140–146
Record MT, Lohman TM, de Haseth P (1976) Ion effects on ligand–nucleic acid interactions. J Mol Biol 107:145–158
Rivas E, Eddy SR (2000) Secondary structure alone is generally not statistically significant for the detection of noncoding RNAs. Bioinformatics 16:583–605
Roberts RB (1958) Microsomal particles and protein synthesis; papers presented at the First Symposium of the Biophysical Society, at the Massachusetts Institute of Technology, Cambridge, February 5, 6, and 8, 1958. New York: Published on behalf of the Washington Academy of Sciences, Washington, D.C., by Pergamon Press
Rosenbach H, Borggräfe J, Victor J et al (2020a) Influence of monovalent metal ions on metal binding and catalytic activity of the 10–23 DNAzyme. Biol Chem 402:99–111
Rosenbach H, Victor J, Etzkorn M et al (2020b) Molecular features and metal ions that influence 10–23 DNAzyme activity. Molecules 25:3100
Ruvkun G (2001) Glimpses of a tiny RNA world. Science 294:797–799
Santoro SW, Joyce GF (1997a) A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci USA 94:4262–4266
Santoro SW, Joyce GF (1997b) A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci USA 94:4262–4266
Schöning K-U, Scholz P, Guntha S et al (2000) Chemical etiology of nucleic acid structure: The α-threofuranosyl-(3′→2′) oligonucleotide system. Science 290:1347–1351
Schubert S, Gül DC, Grunert H-P et al (2003) RNA cleaving “10–23” DNAzymes with enhanced stability and activity. Nucleic Acids Res 31:5982–5992
Sednev MV, Liaqat A, Höbartner C (2022) High-throughput activity profiling of RNA-cleaving DNA catalysts by deoxyribozyme sequencing (DZ-seq). J Am Chem Soc 144:2090–2094
Silverman SK (2009) Deoxyribozymes: Selection design and serendipity in the development of DNA catalysts. Acc Chem Res 42:1521–1531
Silverman SK (2015) Pursuing DNA catalysts for protein modification. Acc Chem Res 48:1369–1379
Silverman SK (2016) Catalytic DNA: Scope, applications, and biochemistry of deoxyribozymes. Trends Biochem Sci 41:595–609
Spitale RC, Chaput JC (2022) Reply to: On gene silencing by the X10–23 DNAzyme. Nat Chem 14:859–861
Steffen FD, Khier M, Kowerko D et al (2020) Metal ions and sugar puckering balance single-molecule kinetic heterogeneity in RNA and DNA tertiary contacts. Nat Commun 11:104
Steger G, Victor J (2022) Design of a DNAzyme. Methods Mol Biol, DNAzymes: 47–63
Taylor AI, Holliger P (2022) On gene silencing by the X10–23 DNAzyme. Nat Chem 14:855–858
Taylor AI, Wan CJK, Donde MJ et al (2022) A modular XNAzyme cleaves long, structured RNAs under physiological conditions and enables allele-specific gene silencing. Nat Chem 14:1295–1305
Travascio P, Li Y, Sen D (1998) DNA-enhanced peroxidase activity of a DNA aptamer–hemin complex. Chem Biol 5:505–517
Vester B, Lundberg LB, Sørensen MD et al (2002) LNAzymes: Incorporation of LNA-type monomers into DNAzymes markedly increases RNA cleavage. J Am Chem Soc 124:13682–13683
Victor J, Steger G, Riesner D (2018) Inability of DNAzymes to cleave RNA in vivo is due to limited Mg2+ concentration in cells. Eur Biophys J 47:333–343
Walsh SM, Sachdeva A, Silverman SK (2013) DNA catalysts with tyrosine kinase activity. J Am Chem Soc 135:14928–14931
Walsh SM, Konecki SN, Silverman SK (2015) Identification of sequence-selective tyrosine kinase deoxyribozymes. J Mol Evol 81:218–224
Wang Y, Nguyen K, Spitale RC et al (2021) A biologically stable DNAzyme that efficiently silences gene expression in cells. Nat Chem 13:319–326
Wong OY, Pradeepkumar PI, Silverman SK (2011) DNA-catalyzed covalent modification of amino acid side chains in tethered and free peptide substrates. Biochemistry 50:4741–4749
Workman C, Krogh A (1999) No evidence that mRNAs have lower folding free energies than random sequences with the same dinucleotide distribution. Nucleic Acids Res 27:4816–4822
Zacchia M, Abategiovanni ML, Stratigis S et al (2016) Potassium: From physiology to clinical implications. Kidney Dis 2:72–79
Zhang J (2018) RNA-cleaving DNAzymes: Old catalysts with new tricks for intracellular and in vivo applications. Catalysts 8:550
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Span, I., Etzkorn, M. (2023). RNA-Processing DNAzymes. In: Barciszewski, J. (eds) RNA Structure and Function. RNA Technologies, vol 14. Springer, Cham. https://doi.org/10.1007/978-3-031-36390-0_28
Download citation
DOI: https://doi.org/10.1007/978-3-031-36390-0_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-36389-4
Online ISBN: 978-3-031-36390-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)